It is yet unclear how diabetes affects sepsis-related mortality, despite the widely held view that inadequate glycemic management contributes to a significant number of severe infections, insulin, metformin, and thiazolidinediones may lower the incidence and fatality rate of sepsis. The gene discussed is INS; the disease is Sepsis.